Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 828 Records) |
| Query Trace: Neoplasms and Alk[original query] |
|---|
| Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report. JTO clinical and research reports 2024 12 5 (12): 100745. Vincent D de Jager, Léon C van Kempen, Betzabel N Cajiao Garcia, T Jeroen N Hiltermann, Anthonie J van der Wekken, Ed Schuuring, Stefan M Wille |
| Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis. Neoplasia (New York, N.Y.) 2024 12 60 101113. Sheng-Kai Liang, Wei-Yu Liao, Jin-Yuan Shih, Chia-Lin Hsu, Ching-Yao Yang, Shang-Gin Wu, Yen-Ting Lin, Yueh-Feng Wen, Lun-Che Chen, Yen-Fu Chen, Ya-Fang Chen, Yen-Heng Lin, Chong-Jen |
| Risk Stratification and Adjuvant Chemotherapy for High-Risk Stage IA Lung Adenocarcinoma: The Unmet Needs. Thoracic cancer 2024 12 . Chen Shen, Haoran Liu, Bofei Li, Jiaming Wang, Yiyang Wang, Feichao Bao, Zhitao Gu, Wentao Fa |
| Outcomes of patients receiving urgent palliative radiotherapy for advanced lung cancer: an observational study. BMC palliative care 2024 12 23 (1): 296. Yang Xu, Celestee Trach, Tracey Tessier, Rishi Sinha, David Skarsga |
| Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer. Translational cancer research 2024 12 13 (11): 6235-6245. Theodore Wang, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Matthew P De |
| PIK3CA Mutations and Co-Mutations in Operated Non-Small Cell Lung Carcinoma. Journal of clinical medicine 2024 12 13 (23): . Salih Cokpinar, Ibrahim Halil Erdogdu, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Nesibe Kahraman-Cetin, Ibrahim Meteog |
| Genetic profile in primary tumor tissue of advanced lung adenocarcinoma patients with adrenal metastasis. Cancer genetics 2024 12 290-291 36-43. Haiqiao Pan, Hongbin Zhang, Yongqian Zhang, Xiaojing Chen, Zhai Liu, Yajing Wu, Na Bai, Yan Shi, Min Zhao, Lingling Z |
| Prognostic impact of targetable driver alterations in resected early-stage lung cancer. Translational lung cancer research 2024 12 13 (11): 3096-3105. Angelika Terbuch, Selma Konjic, Verena Schlintl, Gudrun Absenger, Philipp J Jost, Jörg Lindenmann, Paul Swatek, Nikolaus John, Teresa John, Robert Wurm, Martin Zacharias, Florian Posch, Maximilian J Hochmair, Hannah Fabikan, Christoph Weinlinger, Oliver Illini, Lena Horvath, Gabriele Gamerith, Dominik Wolf, Florian Augustin, Luka Brc |
| Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1. Frontiers in oncology 2024 12 14 1473327. Zachary D Wallen, Mary K Nesline, Marni Tierno, Alison Roos, Erica Schnettler, Hatim Husain, Pratheesh Sathyan, Brian Caveney, Marcia Eisenberg, Eric A Severson, Shakti H Ramkisso |
| Sex and common germline variants impact the toxicity profile and pharmacokinetics of alectinib: a nation-wide cohort study in patients with ALK-positive non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 12 . Niels Heersche, Daan A C Lanser, M Benthe Muntinghe-Wagenaar, Ma Ida Mohmaed Ali, Ezgi B Ulas, Tessa M A Trooster, Evert de Jonge, Esther Oomen-de Hoop, Marthe S Paats, Idris Bahce, Sander Croes, Lizza E L Hendriks, Anthonie J van der Wekken, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H N van Schaik, Ron H J Mathijssen, G D Marijn Veerm |
| Integrative multi-omics profiling of colorectal cancer from a Hispanic/Latino cohort of patients. medRxiv : the preprint server for health sciences 2024 11 . B Waldrup, F Carranza, Y Jin, Y Amzaleg, M Postel, D W Craig, J D Carpten, B Salhia, C N Ricker, J O Culver, C E Chavez, M C Stern, L Baezconde-Garbanati, H J Lenz, E I Velazquez-Villarre |
| The Prevalence of Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Cancer: An Experience From Tertiary Care Hospital. Cureus 2024 11 16 (10): e72291. Asmita Mehta, Lakshmi Priya V P, Lakshmi Teja, Krishna Pill |
| Brief Report: Final overall survival and long-term safety of lorlatinib in patients with ALK-positive non-small cell lung cancer from the pivotal phase 2 study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 11 . Sai-Hong Ignatius Ou, Benjamin J Solomon, Benjamin Besse, Alessandra Bearz, Chia-Chi Lin, Rita Chiari, D Ross Camidge, Jessica J Lin, Antonello Abbattista, Francesca Toffalorio, Ross A S |
| Prognostic significance of actionable next-generation sequencing multigene panel in esophageal cancer treatment. European review for medical and pharmacological sciences 2024 11 28 (21): 4515-4525. Z Teke, A Bisgin, C Oruc Rencuzogullari, K Eren Erdogan, C K Parsak, S Kalkanli T |
| Cytomorphological and histomorphological features of lung adenocarcinoma with epidermal growth factor receptor mutation and anaplastic lymphoma kinase gene rearrangement. Oncology letters 2024 11 29 (1): 40. Nikola Gardi?, Aleksandra Lovrenski, Vanesa Sekeruš, Svetlana Kašikovi? Le?i?, Milorad Bijelovi?, Tanja Laki?, Aleksandra Ili?, Bojan Zari?, Sofija Glum |
| Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 11 . Paloma Navarro, Carmen Beato, Juan Francisco Rodriguez-Moreno, Sergio Ruiz-Llorente, Xabier Mielgo, Estela Pineda, Miguel Navarro, Gema Bruixola, Tatiana P Grazioso, Antonio Viudez, Jose Fuster, Esther Nogueron, Maria Dolores Mediano, Carmen Balaña, Carlos Mendez, Rosa María Rodriguez, Sonia Del Barco Berron, Beatriz Gongora, Alberto Carmona-Bayonas, Jesus Garcia-Don |
| Landscape of C-MET overexpression in non-small cell lung cancer: a large-scale study of clinicomolecular features and prognosis based on Chinese data. Therapeutic advances in medical oncology 2024 10 16 17588359241279715. Shuting Zhan, Jianfu Li, Bo Cheng, Caichen Li, Yi Feng, Lei Fan, Shan Xiong, Wenchuang Zeng, Qi Cai, Yang Xiang, Huiting Wang, Chunyan Li, Peiling Chen, Xin Zheng, Wenhai Fu, Zhexue Hao, Jianxing He, Wenhua Lia |
| Inadequate staging and excessive surveillance imaging: Evaluating the magnitude of benefit of targeted therapies in lung cancer. European journal of cancer (Oxford, England : 1990) 2024 10 212 115058. David J Benjamin, Vinay Pras |
| Genetic Profiling of Non-Small Cell Lung Cancer in Moroccan Patients by Targeted Next-Generation Sequencing. Technology in cancer research & treatment 2024 10 23 15330338241288907. Sara El Zaitouni, Abdelilah Laraqui, Meriem Ghaouti, Asmae Benzekri, Fouad Kettani, Youssra Boustany, Soukaina Benmokhtar, Hafsa Lamrani Alaoui, Hicham El Annaz, Rachid Abi, Mohamed Rida Tagajdid, Safae El Kochri, Bouchra El Mchichi, El Arbi Bouaiti, Idriss Amine Lahlou, Rabii Ameziane El Hassani, Khalid Enni |
| [Clinical characteristics and prognostic factors of epidermal growth factor receptor-mutated non-small cell lung cancer transformed into small-cell lung cancer after treatment]. Zhonghua yi xue za zhi 2024 10 104 (40): 3751-3756. H Zheng, D Zhao, M Gu, Q H Wang, C H Li, X Li, J Li, N Y Che, Y |
| Epidemiological and clinical characteristics of lung cancer in Saudi Arabia: a retrospective study in single oncology center. Oncology research 2024 10 32 (11): 1803-1809. Yousef Katib, Nasser Mul |
| Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer. Journal for immunotherapy of cancer 2024 10 12 (10): . Nicolas Zhou, Cheuk H Leung, William N William, Annikka Weissferdt, Apar Pataer, Myrna C B Godoy, Brett W Carter, Frank V Fossella, Anne S Tsao, George R Blumenschein, Xiuning Le, Jianjun Zhang, Ferdinandos Skoulidis, Jonathan M Kurie, Mehmet Altan, Charles Lu, Bonnie S Glisson, Lauren A Byers, Yasir Y Elamin, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Jack A Roth, Hai T Tran, Jia Wu, Luisa M Solis Soto, Humam Kadara, Stephen G Swisher, Ara A Vaporciyan, Don L Gibbons, Heather Y Lin, J Jack Lee, John V Heymach, Marcelo V Negrao, Boris Sepesi, Tina Casco |
| Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia. Lung cancer (Amsterdam, Netherlands) 2024 10 197 107992. Yuki Kato, Hibiki Udagawa, Shingo Matsumoto, Hiroki Izumi, Yuichiro Ohe, Terufumi Kato, Kazumi Nishino, Shingo Miyamoto, Sachiko Kawana, Kenichi Chikamori, Masato Shingyoji, Yuki Sato, Yuji Takada, Ryo Toyozawa, Koichi Azuma, Yu Tanaka, Tetsuya Sakai, Yuji Shibata, Eri Sugiyama, Kaname Nosaki, Yoshitaka Zenke, Shigeki Umemura, Kiyotaka Yoh, Masahiro Seike, Koichi Go |
| Adenosquamous Carcinoma of the Lung: Survival, Radiologic Findings, PD-L1, and Driver Mutations. Journal of clinical medicine 2024 10 13 (19): . Oliver Illini, Hannah Fabikan, Eva Fischer, Anna Sophie Lang-Stöberl, Dagmar Krenbek, Christa Jarius, Shokoufa Azarnia-Medan, Stefan Gasser, Maximilian Johannes Hochmair, Christoph Weinlinger, Arschang Valipour, Stefan Watz |
| Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial. The Lancet. Oncology 2025 1 26 (1): 74-84. Yanjun Xu, Kaiyan Chen, Yujin Xu, Hui Li, Zhiyu Huang, Hongyang Lu, Dingzhi Huang, Sizhe Yu, Na Han, Lei Gong, Jing Qin, Jun Chen, Fajun Xie, Wei Hong, Xiao Lin, Fengzhuo Cheng, Xiaojie Luo, Yun F |
| Brief report: Impact of consolidation durvalumab on unresectable non-small lung cancer with driver mutations. Cancer treatment and research communications 2025 1 42 100863. Jason C S Ho, K M Cheu |
| Non small cell lung cancer with SMARCA4 deficiency harboring rare EGFR mutations exhibited significant tumor response when treated with afatinib: a case report. Frontiers of medicine 2025 1 . Xiaotong Qiu, Liangkun You, Chongwei Wang, Jin She |
| Real-World Incidence of Anaplastic Lymphoma Kinase alterations in Hispanics with Non-Small Cell Lung Cancer at a Large Academic Institution in Los Angeles. Cancer research communications 2025 1 . Darin Poei, Sana Ali, Jacob S Thomas, Jorge J Nieva, Robert C H |
| RET-AREAL: a multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs. Cancer letters 2025 1 217455. Xinjun Tang, Jie Hu, Renhua Guo, Yina Wang, Yu Yao, Liang Zeng, Haitao Wang, Haibo Shen, Jun Chen, Weina Huang, Lihua Liu, Ming Su, Zhuang Yu, Weidong Mao, Jinliang Wang, Haitao Tao, Guilan Dong, Chang Cai, Yupeng Xie, Tao Qu, Yan Zhang, Wei Shen, Jing Cao, Xin Cai, Wencui Kong, Xiaoxue Li, Fei Lia |
| Enhanced detection of actionable mutations in NSCLC through pleural effusion cell-free DNA sequencing: A prospective study. European journal of cancer (Oxford, England : 1990) 2025 1 217 115224. Hsin-Yi Wang, Wei-Yu Liao, Chao-Chi Ho, Shang-Gin Wu, Ching-Yao Yang, Chia-Lin Hsu, Yen-Ting Lin, James Chih-Hsin Yang, Jin-Yuan Sh |
- Page last reviewed:Feb 1, 2024
- Content source: